» Articles » PMID: 36555771

Manipulation of Amino Acid Levels with Artificial Diets Induces a Marked Anticancer Activity in Mice with Renal Cell Carcinoma

Abstract

Targeted therapies with antiangiogenic drugs (e.g., sunitinib) and immune checkpoint inhibitors (e.g., anti-PD-1 antibodies) are the standard of care for patients with metastatic renal cell carcinoma. Although these treatments improve patient survival, they are rarely curative. We previously hypothesized that advanced cancers might be treated without drugs by using artificial diets in which the levels of specific amino acids (AAs) are manipulated. In this work, after showing that AA manipulation induces selective anticancer activity in renal cell carcinoma cells in vitro, we screened 18 artificial diets for anticancer activity in a challenging animal model of renal cell carcinoma. The model was established by injecting murine renal cell carcinoma (Renca) cells into the peritoneum of immunocompetent BALB/cAnNRj mice. Mice survival was markedly improved when their normal diet was replaced with our artificial diets. Mice fed a diet lacking six AAs (diet T2) lived longer than mice treated with sunitinib or anti-PD-1 immunotherapy; several animals lived very long or were cured. Controlling the levels of several AAs (e.g., cysteine, methionine, and leucine) and lipids was important for the anticancer activity of the diets. Additional studies are needed to further evaluate the therapeutic potential and mechanism of action of this simple and inexpensive anticancer strategy.

Citing Articles

Potential involvement of cuproptosis induced by m6A-modified autophagy gene ATG10 in KICH : Cuproptosis induced by m6A-modified ATG10 in KICH.

Zhu Q, Fu D, Zhu Z, Wu J, Li C, Chen J BMC Cancer. 2024; 24(1):1591.

PMID: 39736548 PMC: 11686867. DOI: 10.1186/s12885-024-13300-8.


A Diet Lacking Selenium, but Not Zinc, Copper or Manganese, Induces Anticancer Activity in Mice with Metastatic Cancers.

Diaz-Ortega P, Calderon-Montano J, Jimenez-Alonso J, Guillen-Mancina E, Jimenez-Gonzalez V, Burgos-Moron E Nutrients. 2024; 16(14).

PMID: 39064692 PMC: 11280272. DOI: 10.3390/nu16142249.


Dietary Manipulation of Amino Acids for Cancer Therapy.

Jimenez-Alonso J, Lopez-Lazaro M Nutrients. 2023; 15(13).

PMID: 37447206 PMC: 10346484. DOI: 10.3390/nu15132879.


Artificial Diets with Altered Levels of Sulfur Amino Acids Induce Anticancer Activity in Mice with Metastatic Colon Cancer, Ovarian Cancer and Renal Cell Carcinoma.

Jimenez-Alonso J, Guillen-Mancina E, Calderon-Montano J, Jimenez-Gonzalez V, Diaz-Ortega P, Burgos-Moron E Int J Mol Sci. 2023; 24(5).

PMID: 36902018 PMC: 10003419. DOI: 10.3390/ijms24054587.


Artificial Diets with Selective Restriction of Amino Acids and Very Low Levels of Lipids Induce Anticancer Activity in Mice with Metastatic Triple-Negative Breast Cancer.

Guillen-Mancina E, Jimenez-Alonso J, Calderon-Montano J, Jimenez-Gonzalez V, Diaz-Ortega P, Burgos-Moron E Cancers (Basel). 2023; 15(5).

PMID: 36900331 PMC: 10000978. DOI: 10.3390/cancers15051540.

References
1.
Jimenez-Alonso J, Guillen-Mancina E, Calderon-Montano J, Jimenez-Gonzalez V, Diaz-Ortega P, Burgos-Moron E . Artificial Diets Based on Selective Amino Acid Restriction versus Capecitabine in Mice with Metastatic Colon Cancer. Nutrients. 2022; 14(16). PMC: 9412877. DOI: 10.3390/nu14163378. View

2.
Humayun M, Turner J, Elango R, Rafii M, Langos V, Ball R . Minimum methionine requirement and cysteine sparing of methionine in healthy school-age children. Am J Clin Nutr. 2006; 84(5):1080-5. DOI: 10.1093/ajcn/84.5.1080. View

3.
Tajan M, Vousden K . Dietary Approaches to Cancer Therapy. Cancer Cell. 2020; 37(6):767-785. DOI: 10.1016/j.ccell.2020.04.005. View

4.
Snaebjornsson M, Janaki-Raman S, Schulze A . Greasing the Wheels of the Cancer Machine: The Role of Lipid Metabolism in Cancer. Cell Metab. 2019; 31(1):62-76. DOI: 10.1016/j.cmet.2019.11.010. View

5.
Bian Y, Li W, Kremer D, Sajjakulnukit P, Li S, Crespo J . Cancer SLC43A2 alters T cell methionine metabolism and histone methylation. Nature. 2020; 585(7824):277-282. PMC: 7486248. DOI: 10.1038/s41586-020-2682-1. View